cdk4 glutathione MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation Addressing delivery and resistance issues
Addressing delivery and resistance issues of CDK4 6 inhibitors as cancer therapeutics ScienceDirect Inhibition of METTL14 overcomes CDK4 6 inhibitor resistance driven by METTL14 m6A E2F1 axis in ER positive breast cancer Journal of Nanobiotechnology Springer Nature Link CDK4 and CDK6 kinases: From basic science to cancer therapy Science Cyclin D Cdk4,6 drives cell cycle progression via the retinoblastoma protein's C terminal helix bioRxiv Cyclin D CDK4 Disulfide Bond Attenuates Pulmonary Vascular Cell Proliferation Circulation Research CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis Competent Conformations, Offering Drug Targets JACS Au
Pay in 4 interest-free payments of $6.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





